Cadila has highest approvals and I strongly feel pharma is turning around.
Sun pharma has many complex products lined up for launch. Also, they have not been able to launxh some products and had to forego business due to halol plant issue. That is a non issue now. They will make at least 500 cr net in 19_20 from this site.
Zydus has already launched trastuzumab and bevacizumab in india and these will be later launched in EU_US in another 2 years. More biological products are in pipeline.
Granules is another scrip that will be good bet around 80 (I had earlier bought @ 73 sold @100). I look forward to again but this for 100 % return in 2 years (rs 150).